Conventional denuders made of glass or metal are too heavy and bulky to be used in personal sampling systems. In this study, a portable Porous Membrane Denuder (PMD) was developed for personal sampling. The PMD utilizes the porosity of the membrane material and a configuration of multiple parallel flow channels to reduce the size and weight of the device, while increasing the gas collection efficiency. Four types of PMDs (PMD I, II, III and IV) with increasing numbers of channels and smaller channel openings were constructed and tested. Using 10% sodium carbonate coating and a feed concentration of 1 ppm, PMD Ia's collection efficiency for sulfur dioxide over 8 hours was higher than 99.9%. For a feed concentration of 10 ppm, the 5-hr time-weighted-average collection efficiency for sulfur dioxide was 73.1%, 82.8%, 90.9%, 97.2% for PMD Ib, II, III and IV, respectively, compared with 96.6% of the Glass Honeycomb Denuder (GHD), which has similar structure to PMD IV. However, the weight of PMD IV is only one-tenth of that of the GHD. It is clear that with a similar physical structure, PMDs have similar capacities to traditional Glass Honeycomb Denuders, yet are much lighter and less expensive. This study demonstrates the great potential of this new type of denuder for many applications in the field of environmental and industrial hygiene monitoring. Particle loss fractions of the four types of PMDs in the size range of 1 to 10 μm were also measured and were 2.9%, 5.2%, 5.7% and 7.3%, respectively.

OBJECTIVES/GOALS: In vitro models that mimic the human respiratory system are needed to assess the toxicity of inhaled contaminants. Therefore, our goal is to establish a Dosimetric Aerosol in-Vitro Inhalation Device (DAVID) that delivers aerosols in different patterns to human lung cells cultured at an air-liquid interface (ALI). METHODS/STUDY POPULATION: The collection unit of DAVID was modified in this study to accommodate different deposition patterns (spots, annular ring, rectangle & circle). CuO aerosols of varying concentrations were generated using a 6-jet Collison nebulizer for varying time periods to achieve different doses. To quantify the doses that were delivered to cells, the samples were digested with nitric acid & analyzed by Inductively Coupled Plasma-Optical Emission Spectrometry. Following the exposure of A549 cells to CuO aerosols, cytotoxicity and mRNA expression (i.e., HMOX1 & IL-8) will be assessed via LDH and RT-qPCR to determine the effect of regional (mass deposited/area of the pattern) and global (mass deposited/area of the cell culture insert) doses in cells. RESULTS/ANTICIPATED RESULTS: The deposition areas covered by rectangular, spot, annular ring, and circular patterns are estimated to be 6, 17, 27 and 85% of the insert’s surface area, onto which cells are cultured. Results for the patterns tested (spots and annular ring) show that both the regional and global doses were greater for spots than annular ring. Also, the regional doses were higher than global doses. Irrespective of the patterns, the global doses were the same for nebulizer suspensions of 0.1-1 mg/mL. Statistical analysis by ANOVA revealed there was no significant difference in doses between replicate inserts used in the same trial. We anticipate that regional doses with aerosol deposition to a larger surface area of the cell culture insert will correspond with higher cytotoxicity and mRNA expression of HMOX1 and IL-8 in cells. DISCUSSION/SIGNIFICANCE: There are limited in vitro exposure systems that can efficiently deliver aerosols to lung cells, while also mimicking inhalation by humans. In addition to addressing this knowledge gap, we will show the role of regional & global doses in studying cellular response & the ability of DAVID to deliver aerosols in different deposition patterns.